Skip to content

Dose escalation trial of BNT152+153 in patients with cancer

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-509508-13-00
Acronym
BNT152-01C
Enrollment
2
Registered
2024-02-08
Start date
2022-10-04
Completion date
2025-09-10
Last updated
2025-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Various solid tumors that are metastatic or unresectable

Interventions

None listed

Sponsors

BioNTech SE
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Czechia

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026